by Jason Heaviland | Apr 21, 2026
Decoding Alzheimer’s Disease with Multi-Omics Alzheimer’s disease involves coordinated changes across metabolism, proteins and cellular systems. By combining metabolomics and proteomics, this study examines how these changes relate within the same biological...
by Jason Heaviland | Apr 20, 2026 | Uncategorized
Alzheimer’s as a System-Level Disorder via Multi-Omics Alzheimer’s disease is not driven by a single pathway, molecule or mutation. Instead, it reflects a system-level breakdown across metabolism, protein regulation and cellular signaling. Yet most studies still...
by Jason Heaviland | Apr 15, 2026
This study presents an integrated proteomics and metabolomics analysis of Alzheimer’s disease using serum samples. Across 11,000+ molecular features, Panome Bio identified systemic metabolic dysregulation, lipid transport disruption, and protein-level changes...
by Jason Heaviland | Dec 10, 2025 | Uncategorized
The Multi-Omics Imperative in Modern Biology Complex diseases, therapeutic responses, and biological phenotypes rarely result from perturbations in single molecular pathways. Instead, they emerge from intricate interactions spanning genes, transcripts, proteins, and...
by Jason Heaviland | Dec 9, 2025
ChatGJP: LC-MS Proteomics, Multi-Omics, & Precision Medicine In this episode of the ChatGJP series, Panome Bio CSO Dr. Gary J. Patti discusses the strengths and limitations of LC–MS–based proteomics compared to affinity-based approaches, highlighting why mass...
